• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对比剂肾病的最新问题。

Recent issues in contrast-induced nephropathy.

机构信息

Department of Radiology, Kobe University Graduate School of Medicine, Kobe, Japan.

出版信息

Int J Urol. 2011 Oct;18(10):686-90. doi: 10.1111/j.1442-2042.2011.02830.x. Epub 2011 Aug 11.

DOI:10.1111/j.1442-2042.2011.02830.x
PMID:21834851
Abstract

Contrast-induced nephropathy (CIN) is a serious complication resulting from the use of iodinated contrast medium (CM) with potentially high morbidity and mortality. Patients with pre-existing renal insufficiency appear to be at higher risk of CIN. To prevent CIN among patients undergoing contrast-enhanced computed tomography, every effort is required, including routine identification of at-risk patients, the use of appropriate hydration regimens, withdrawal of nephrotoxic drugs, selection of low-osmolality CM or iso-osmolar CM, and using the minimum volume of CM possible.

摘要

对比剂肾病(CIN)是使用碘造影剂(CM)后可能导致的严重并发症,具有较高的发病率和死亡率。有基础肾功能不全的患者似乎面临更高的 CIN 风险。为预防行增强 CT 检查的患者发生 CIN,需要采取一切措施,包括常规识别高危患者、使用合适的水化方案、停用肾毒性药物、选择低渗或等渗 CM 以及尽可能减少 CM 用量。

相似文献

1
Recent issues in contrast-induced nephropathy.对比剂肾病的最新问题。
Int J Urol. 2011 Oct;18(10):686-90. doi: 10.1111/j.1442-2042.2011.02830.x. Epub 2011 Aug 11.
2
What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.与当前证据支持的措施相比,放射科医生在预防对比剂肾病(CIN)方面做了些什么?一项针对欧洲放射科医生关于计算机断层扫描相关CIN的调查。
Acta Radiol. 2008 Apr;49(3):310-20. doi: 10.1080/02841850701858257.
3
Contrast-induced nephropathy--prevention and risk reduction.对比剂肾病——预防与风险降低
Nephrol Dial Transplant. 2006 Jun;21(6):i11-23. doi: 10.1093/ndt/gfl215.
4
Prevention of iodinated contrast-induced nephropathy.预防碘造影剂肾病。
Chin Med J (Engl). 2011 Dec;124(23):4079-82.
5
Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.使用氯化钠盐水水化和N-乙酰半胱氨酸预防接受冠状动脉造影的不同高危和低危患者群体中的造影剂诱导的肾病。
Minerva Cardioangiol. 2010 Feb;58(1):35-40.
6
Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures.对比剂诱导的肾病的预防:针对接受心血管介入手术的高危患者的建议。
Catheter Cardiovasc Interv. 2007 Jan;69(1):135-40. doi: 10.1002/ccd.20964.
7
Contrast-induced nephropathy: the wheel has turned 360 degrees.造影剂肾病:情况又回到了原点。
Acta Radiol. 2008 Jul;49(6):646-57. doi: 10.1080/02841850801995413.
8
Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention.对比剂肾病的结局:心血管介入治疗患者的经验
Catheter Cardiovasc Interv. 2006 Mar;67(3):335-43. doi: 10.1002/ccd.20658.
9
[Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].[采用水化、口服N-乙酰半胱氨酸、碳酸氢钠及等渗对比剂预防心脏导管插入术所致对比剂肾病]
J Cardiol. 2007 Aug;50(2):119-26.
10
The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.经皮冠状动脉介入治疗患者中对比剂肾病的预防
Minerva Cardioangiol. 2004 Oct;52(5):419-32.

引用本文的文献

1
Comparison of changes in creatinine clearance in patients undergoing optical coherence tomography versus intravascular ultrasound.光学相干断层扫描与血管内超声检查患者的肌酐清除率变化比较。
Postepy Kardiol Interwencyjnej. 2025 Mar;21(1):55-62. doi: 10.5114/aic.2025.147708. Epub 2025 Feb 16.
2
Elevated high-sensitivity C-reactive protein combined with procalcitonin predicts high risk of contrast-induced nephropathy after percutaneous coronary intervention.高敏 C 反应蛋白联合降钙素原预测经皮冠状动脉介入治疗后对比剂诱导肾病的高危风险。
BMC Cardiovasc Disord. 2019 Jun 24;19(1):152. doi: 10.1186/s12872-019-1137-9.
3
Safety and Efficacy of Tolvaptan for the Prevention of Contrast-Induced Acute Kidney Injury in Patients with Heart Failure and Chronic Kidney Disease.
托伐普坦预防心力衰竭合并慢性肾脏病患者造影剂所致急性肾损伤的安全性和有效性
Kidney Dis (Basel). 2019 Mar;5(2):100-106. doi: 10.1159/000494724. Epub 2018 Nov 29.
4
Intravenous N-acetylcysteine for the PRevention Of Contrast-induced nephropathy - a prospective, single-center, randomized, placebo-controlled trial. The INPROC trial.静脉注射N-乙酰半胱氨酸预防造影剂肾病——一项前瞻性、单中心、随机、安慰剂对照试验。INPROC试验。
Postepy Kardiol Interwencyjnej. 2018;14(1):59-66. doi: 10.5114/aic.2018.74356. Epub 2018 Mar 22.
5
Diagnostic accuracy of contrast-enhanced ultrasound in assessing the therapeutic response to radio frequency ablation for liver tumors: systematic review and meta-analysis.超声造影评估射频消融治疗肝脏肿瘤疗效的诊断准确性:系统评价和荟萃分析。
Surg Endosc. 2018 Apr;32(4):2067-2075. doi: 10.1007/s00464-017-5903-4. Epub 2017 Dec 21.
6
Efficacy of oral supplemental hydration for the prevention of contrast-induced nephropathy in rats.口服补充水分预防大鼠造影剂肾病的疗效
Jpn J Radiol. 2017 Apr;35(4):190-196. doi: 10.1007/s11604-017-0620-4. Epub 2017 Feb 15.